Clinical Evaluation of the Sentosa SA HSV1/2 Qualitative PCR Test

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

2295 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-04-30

Study Completion Date

2017-04-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate the performance of the Sentosa SA HSV1/2 Qualitative PCR Test. Precision of results and concordance of results with a reference assay will be evaluated.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Safety and Efficacy Study of Herpes Simplex Virus Type 2 (HSV-2) Therapeutic DNA Vaccine

NCT02837575

Herpes Genitalis

COMPLETED PHASE2

Examining the Ability of Herpes Simplex Virus Type 2 (HSV2) Therapy to Reduce HIV Target Cell Numbers in the Cervix

NCT00946556

Herpes Simplex Type Two Infection HIV Infections

COMPLETED NA

Safety Evaluation of Herpes Simplex Candidate Vaccine (gD2t) With Adjuvant in HSV Seropositive / Seronegative Subjects

NCT00698568

Prophylaxis for Herpes Simplex

COMPLETED PHASE3

Comparative Safety and Efficacy of Two Antiviral Treatments in the Treatment of Recurrent Herpes Simplex Labialis

NCT02265913

Herpes Labialis

COMPLETED PHASE3

Evaluating New Formulation of Therapeutic HSV-2 Vaccine

NCT02515175

Genital Herpes Simplex Type 2

COMPLETED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study will utilize residual samples from male and female patients with signs and symptoms of oral or genital HSV infections. Genital samples will include internal and external genital lesions such as those collected from lesions of the anus, buttocks, vagina, labia, or penis. Oral samples will include those collected from lip, gum, and mouth lesions. For concordance testing, the sample size is based on historical study design and estimates of the expected prevalence of HSV1 and/or HSV2 in the population enrolled.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Herpes Simplex

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Vela Sentosa SA HSV1/2 PCR Test

Male and female subjects of any age with sample collected from a lesion and submitted to a clinical laboratory for the purpose of testing for the presence of HSV1 or HSV2 and diagnosing HSV infection.

Vela Sentosa SA HSV1/2 Qualitative PCR Test

Intervention Type DEVICE

medical device test using Vela Sentosa SA HSV1/2 Qualitative PCR Test

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Vela Sentosa SA HSV1/2 Qualitative PCR Test

medical device test using Vela Sentosa SA HSV1/2 Qualitative PCR Test

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Sentosa HSV Assay

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Sample was taken from a lesion from an internal or external oral or genital site.
* Sample was submitted to a clinical laboratory for the purpose of testing for the presence of HSV1 or HSV2.
* The following information about the patient from which the sample was taken is available: presumptive diagnosis or signs and symptoms causing assay requisition; site of lesion; age at time of sample collection or date of birth, and sex.
* Sample was collected in universal viral transport media, using a plastic shaft swab made of either polyester, cotton, rayon or Dacron.
* There is sufficient residual sample to perform both test and reference assays.

Exclusion Criteria

* Sample leaked during shipment or storage prior to assay.
* Sample has undergone more than 1 freeze-thaw cycle before testing;
* Sample eluent is not clear after centrifugation (refer to section 6.3.1).
* Sample ID is missing or ambiguous.
* Sample is collected using alginate calcium swab.
* Sample handling and storage requirement in section 5.4 not followed

Eligible Sex

ALL

Accepts Healthy Volunteers

No